Price
Target price
€37.20
€37.20
13.410%
4.4
13.410%
€37.71
17:43 / Tradegate
WKN: A1W2RM / Symbol: AGIO / Name: Agios / Stock / Biotechnology & Medical Research / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Agios Pharmaceuticals Inc. Stock
A very strong showing by Agios Pharmaceuticals Inc. today, with an increase of €4.40 (13.410%) compared to yesterday's price.
Agios Pharmaceuticals Inc. is currently one of the favorites of our community with 19 Buy predictions and no Sell predictions.
On the other hand, the target price of 37 € is below the current price of 37.2 € for Agios Pharmaceuticals Inc., so the potential is actually -0.54%.
So far the community has only identified positive things for Agios Pharmaceuticals Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Agios Pharmaceuticals Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Agios Pharmaceuticals Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals Inc. | 13.410% | -1.796% | 33.333% | 12.329% | 41.379% | 31.200% | -30.257% |
| Ligand Pharmaceuticals | 0.000% | 2.190% | 35.922% | 187.179% | 68.675% | 324.242% | 157.117% |
| United Therapeutics | 1.380% | 0.315% | 0.315% | 92.129% | 11.959% | 144.581% | 206.667% |
| Ionis Pharmaceuticals Inc. | 0.910% | 2.974% | 12.535% | 97.555% | 7.004% | 89.671% | 118.575% |
Comments
Agios Pharmaceuticals (AGIO) had its price target raised by Truist Financial Corporation from $36.00 to $41.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target lowered by Bank of America Corporation from $41.00 to $40.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
Agios Pharmaceuticals (AGIO) had its price target lowered by Truist Financial Corporation from $39.00 to $36.00. They now have a "buy" rating on the stock.
Show more
Ratings data for AGIO provided by MarketBeat
News
Agios Pharmaceuticals Touts Mitapivat Gains Despite Sickle Cell Pain Miss
Key Points
- Interested in Agios Pharmaceuticals, Inc.? Here are five stocks we like better.
- Agios reported encouraging mitapivat data in thalassemia, saying long-term extension results from
Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances
Key Points
- Interested in Agios Pharmaceuticals, Inc.? Here are five stocks we like better.
- Agios said its rare hematology strategy is gaining momentum, pointing to a “very strong” early launch
Here's Why Shares in Agios Pharmaceuticals Soared This Week (And What to Expect Next in 2026)
Shares in Agios Pharmaceuticals (NASDAQ: AGIO) rose by 11.2% this week, putting the stock into positive territory for the year. The move comes after a well-received first-quarter earnings report
